Overview

The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients

Status:
Unknown status

Trial end date:
2006-12-01

Target enrollment:
0

Participant gender:
All

Summary

We hypothesized that patient will success in benzodiazepine withdrawal if they get melatonin to solve sleep-problems which commonly occur during benzodiazepine withdrawal. Former heroin addicts, currently in Methadone maintenance treatment, who are also abusing benzodiazepine, started self benzodiazepine withdrawal, and got for 6 weeks melatonin (5mg/day, taken every night) or placebo and after 1 week, additional 6 weeks with placebo or melatonin (double blind for what got first).Success The benzodiazepine withdrawal success was evaluated by urine for benzodiazepines, and sleep quality was evaluated using PSQI questionnaire (baseline,and after weeks 6, 7, 13)

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Tel-Aviv Sourasky Medical Center

Treatments:

Melatonin

Criteria

Inclusion Criteria:

- Former opiates addicts, currently in methadone maintenance treatment, and abusing
benzodiazepines who intend to withdrawal

- adults (>=18y)

Exclusion Criteria:

- non abusing benzodiazepine

- Refuse making benzodiazepines withdrawal

- non methadone maintenance treatment patients